Rothwell Investment Advisors, LLC’s Globus Medical GMED Stock Holding History

Rothwell Investment Advisors, LLC’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$86.7K	Buy	+1,157	New	+$91.6K	0.05%	305

Other funds holding GMED

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Antipodes Partners Royal Exchange, Australia $5.43B AUM 15.86% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Anchor Capital Advisors Boston, Massachusetts $3.21B AUM 13.78% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Rothwell Investment Advisors, LLC's GMED Position: Q3 2026 in Review

Rothwell Investment Advisors, LLC opened a new position in Globus Medical (GMED) in Q3 2026: 1,157 shares worth $86.7K. The stake represents 0.05% of the portfolio and ranks #305 among its holdings.

295 funds tracked by Wall St. Rank hold GMED as of Q3 2026.

Rothwell Investment Advisors, LLC held 1,157 shares of Globus Medical worth $86.7K as of Q3 2026.
Globus Medical was a new Rothwell Investment Advisors, LLC position in Q3 2026.
Globus Medical made up 0.05% of Rothwell Investment Advisors, LLC's portfolio in Q3 2026, its #305 holding.
295 funds tracked by Wall St. Rank held Globus Medical as of Q3 2026.

Based on Rothwell Investment Advisors, LLC's 13F filing for Q3 2026, filed 6 Nov 2026.